Naltrexone for the treatment of trichotillomania: a case report
Carrion, V.G.
Journal of Clinical Psychopharmacology 15(6): 444-445
1995
ISSN/ISBN: 0271-0749 PMID: 8748437 Document Number: 454823
Document emailed within 1 workday
Related Documents
Muller, G.; Grieshaber, R.; Talley, J.Floyd.; Riepl, M.; Fellows, D. 2018: Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report International Journal of Pharmaceutical Compounding 22(4): 270-278Nuss, M.A.; Carlisle, D.; Hall, M.; Yerneni, S.C.; Kovach, R. 2003: Trichotillomania: a review and case report Cutis 72(3): 191-196
Grant, J.E.; Kim, S.W. 2002: Adolescent kleptomania treated with naltrexone--a case report European Child and Adolescent Psychiatry 11(2): 92-95
Malspeis, L.; Bathala, M.S.; Ludden, T.M.; Bhat, H.B.; Frank, S.G.; Sokoloski, T.D.; Morrison, B.E.; Reuning, R.H. 1975: Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol Research Communications in Chemical Pathology and Pharmacology 12(1): 43-65
Huismans, H. 1976: A case of trichotillomania Klinische Monatsblatter für Augenheilkunde 168(6): 850-851
Bhanji, N.H.; Margolese, H.C. 2004: Alternative pharmacotherapy for trichotillomania: a report of successful bupropion use Journal of Clinical Psychiatry 65(9): 1283
Sheikha, S.H.; Wagner, K.D.; Wagner, R.F. 1993: Fluoxetine treatment of trichotillomania and depression in a prepubertal child Cutis 51(1): 50-52
Hemmings, Sîan.M.J.; Kinnear, C.J.; Lochner, C.; Seedat, S.; Corfield, V.A.; Moolman-Smook, J.C.; Stein, D.J. 2006: Genetic correlates in trichotillomania--A case-control association study in the South African Caucasian population Israel Journal of Psychiatry and Related Sciences 43(2): 93-101
Akkök, F. 1995: The effects of naltrexone in autistic children: report of two cases Turkish Journal of Pediatrics 37(1): 19-23
Kim, S.W.; Grant, J.E.; Adson, D.E.; Remmel, R.P. 2001: A preliminary report on possible naltrexone and nonsteroidal analgesic interactions Journal of clinical psychopharmacology 21(6): 632-634
Crockford, D.N.; el-Guebaly, N. 1998: Naltrexone in the treatment of pathological gambling and alcohol dependence Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 43(1): 86
Manudhane, A.P.; Schrom, K.P.; Ezaldein, H.H.; Armile, J.A. 2019: Low-dose naltrexone: a unique treatment for amyopathic dermatomyositis Dermatology Online Journal 25(6)
Van Brussel, G.H. 2001: Limited role of naltrexone in the treatment of opiate addiction Nederlands Tijdschrift Voor Geneeskunde 145(30): 1452-1456
Bieńkowski, P.ła. 2013: Pharmacological features of naltrexone and its use in the treatment of alcohol dependence Psychiatria Polska 47(1): 117-126
Tortelly, V.D.; De Mattos, T.; Fernandes, L.S.d.A.; Nunes, B.E.M.; Melo, D.F. 2019: Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias? Dermatology Online Journal 25(8)
Kenny, D.E. 1994: Use of naltrexone for treatment of psychogenically induced dermatoses in five zoo animals Journal of the American Veterinary Medical Association 205(7): 1021-1023
Ochoa Mangado, E.; Arias Horcajadas, F. 2000: Alcohol consumption in opioid-dependence patients in treatment with naltrexone Actas Espanolas de Psiquiatria 28(4): 239-249
Faro, G.; Jarre, P.; Martucci, M.; Sargiotto, A.; Eandi, M. 1991: Use of naltrexone in the treatment of opiate addicts. Efficacy and indications for type categories La Clinica Terapeutica 139(3-4): 93-99
Lahti, T.; Halme, J.T.; Pankakoski, M.; Sinclair, D.; Alho, H. 2010: Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study Psychopharmacology Bulletin 43(3): 35-44
Namkoong, K.; Farren, C.K.; O'Connor, P.G.; O'Malley, S.S. 1999: Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications Journal of Clinical Psychiatry 60(7): 449-453